Investor Relations Home
|IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries.
|05/24/17||IRIDEX To Present At The Jefferies 2017 Global Healthcare Conference|
|MOUNTAIN VIEW, Calif., May 24, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Jefferies 2017 Global Healthcare Conference in New York, NY.
IRIDEX's management is scheduled to present on Wednesday, June 7, 2017 at 4:30pm ET. Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com.
IRIDEX Corporation was founded in 1989 and is a w... |
|05/04/17||IRIDEX Announces Presentation Of Data Demonstrating Safety And Efficacy Of Micropulse® Technology At Upcoming Industry Conferences|
|Results will be highlighted at upcoming ASCRS congress May 5-9 and ARVO annual meeting May 7-11
MOUNTAIN VIEW, Calif., May 4, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the presentation of data demonstrating the safety and efficacy of its proprietary MicroPulse® technology for treating glaucoma and retinal disease at the upcoming American Society of Cataract and Refractive Surgery Symposium & Congress (ASCRS) and Association for Research in Vision and Ophthalmo... |
|05/03/17||IRIDEX Announces First Quarter 2017 Financial Results|
|Updates Guidance for Full Year 2017
MOUNTAIN VIEW, Calif., May 3, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months ended April 1, 2017.
Recent Financial Results and Highlights
Total revenue of $10.5 million for the first quarter of 2017, a 12% decrease year over year
Cyclo G6™ glaucoma laser platform revenues in the first quarter of 2017 grew in the low double digits year over year
|04/19/17||IRIDEX to Report First Quarter 2017 Financial Results on May 3, 2017|
|MOUNTAIN VIEW, Calif., April 19, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the first quarter 2017 after the close of trading on Wednesday, May 3, 2017. The Company's management team will host a corresponding conference call beginning at 2:30 p.m. PT / 5:30 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 3... |
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.